Crossref
Fulminant Immune Checkpoint Inhibitor Cardio Myotoxicity Successfully Managed with Early Targeted Immunosuppression
Heart, Lung and Circulation · 2026-06 · 35 · S48
DOI: 10.1016/j.hlc.2026.04.059 ↗Kurz gefasst
Fachartikel in der Zeitschrift Heart, Lung and Circulation, 2026-06. Verfasst von J. Benatar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Benatar, J. (2026). Fulminant Immune Checkpoint Inhibitor Cardio Myotoxicity Successfully Managed with Early Targeted Immunosuppression. Heart, Lung and Circulation, 35, S48. https://doi.org/10.1016/j.hlc.2026.04.059
Vancouver
Benatar J. Fulminant Immune Checkpoint Inhibitor Cardio Myotoxicity Successfully Managed with Early Targeted Immunosuppression. Heart, Lung and Circulation. 2026;35:S48. doi:10.1016/j.hlc.2026.04.059
BibTeX
@article{Benatar2026,
author = {Benatar, J.},
title = {Fulminant Immune Checkpoint Inhibitor Cardio Myotoxicity Successfully Managed with Early Targeted Immunosuppression},
journal = {Heart, Lung and Circulation},
year = {2026},
volume = {35},
pages = {S48},
doi = {10.1016/j.hlc.2026.04.059}
}
EUVIMED